ICU Medical, Inc.
ICUI
Market Cap$2.45B
Close$
$182.89
86.2% upside
Current Fair Value
86.2% upsideUndervalued by 86.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.45 Billion |
|---|---|
| Enterprise Value | $3.83 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.23 |
| Beta | 1.4 |
| Outstanding Shares | 24,365,082 |
| Avg 30 Day Volume | 257,405 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -82.78 |
|---|---|
| PEG | -798.29 |
| Price to Sales | 1.07 |
| Price to Book Ratio | 1.13 |
| Enterprise Value to Revenue | 1.7 |
| Enterprise Value to EBIT | 80.08 |
| Enterprise Value to Net Income | -130 |
| Total Debt to Enterprise | 0.43 |
| Debt to Equity | 0.77 |
Revenue Sources
No data
ESG Score
No data
About ICU Medical, Inc.
9,000 employees
CEO: Vivek Jain ICU Medical, Inc. is a San Clemente, California-based company with global operations that develops, manufactures, and sells medical technologies used in vascular therapy, oncology, and critical care applications. ICU Medical’s products a...